Shukra Pharmaceuticals Limited

About

Shukra Pharmaceuticals Limited manufactures and markets pharmaceutical products in India and internationally. Its product portfolio includes macrolides, quinolones, anti-bacterial, anti-fungal, anti-malarial, anti-viral, anti-protozoal, anti-anthelmintic, sedative and tranquillizer, anti-depressant, anti-manic, anti-emetic, anti-ulcer, beta blockers, diuretics, analgesic, muscle relaxants, anti-tuberculosis, vitamin products, anti-allergics, corticosteroids, hyper and hypoglycemic, and other products, as well as antibiotics, such as penicillin and cephalosporin. The company was formerly known as Relish Pharmaceuticals Limited and changed its name to Shukra Pharmaceuticals Limited in August 2016. Shukra Pharmaceuticals Limited was incorporated in 1993 and is based in Ahmedabad, India.

Key Metrics

as of Sep 2026

Market Cap2,280 Cr

P/E67.10

Div Yield0.02 %

Book Value₹2.05

52w High₹65.30

52w Low₹26.20

Face Value₹1.00

Quarterly Results

Rs. Crores · hover row for definition

Metric	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024
Sales	24.00	6.00	39.00	6.00	5.00	13.00	11.00
Expenses	4.00	6.00	12.00	6.00	4.00	6.00	7.00
Operating Profit	19.00	1.00	27.00	0.00	1.00	7.00	4.00
OPM %	81.00	11.00	69.00	-7.00	24.00	55.00	37.00
Other Income	1.00	1.00	1.00	2.00	1.00	1.00	1.00
Depreciation	1.00	1.00	1.00	1.00	1.00	1.00	1.00
Interest	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Profit before tax	18.00	0.00	27.00	0.00	1.00	8.00	4.00
Tax %	29.00	553.00	24.00	-1,090.00	26.00	29.00	23.00
Net Profit	13.00	-2.00	20.00	2.00	1.00	5.00	3.00
EPS in Rs	0.29	-0.04	0.46	0.05	0.02	0.12	0.07

Profit & Loss

Annual · Rs. Crores

Metric	Mar 2026	Mar 2025
Sales	57.00	33.00
Expenses	28.00	20.00
Operating Profit	29.00	13.00
OPM %	51.00	39.00
Other Income	5.00	4.00
Interest	1.00	1.00
Depreciation	3.00	3.00
Profit before tax	29.00	13.00
Tax %	23.00	28.00
Net Profit	22.00	10.00
EPS in Rs	0.50	0.22
Dividend Payout %	2.00	0.00

Balance Sheet

Annual · Rs. Crores — latest first

Metric	Mar 2026	Mar 2025
Equity Capital	44.00	44.00
Reserves	46.00	19.00
Borrowings	5.00	4.00
Other Liabilities	23.00	20.00
Total Liabilities	117.00	87.00
Fixed Assets	22.00	19.00
CWIP	12.00	2.00
Investments	0.00	0.00
Other Assets	84.00	65.00
Total Assets	117.00	87.00

Cash Flows

Annual · Rs. Crores — latest first

Metric	Mar 2026	Mar 2025
Cash from Operating Activity	4.00	8.00
Cash from Investing Activity	-14.00	-1.00
Cash from Financing Activity	4.00	-5.00
Net Cash Flow	-6.00	2.00
Free Cash Flow	-12.00	5.00
CFO/OP %	19.00	92.00

Ratios

Annual · Days / % — latest first

Metric	Mar 2026	Mar 2025
Debtor Days	148.00	98.00
Inventory Days	320.00	447.00
Days Payable	232.00	414.00
Cash Conversion Cycle	236.00	131.00
Working Capital Days	352.00	403.00
ROCE %	37.00	—

Shareholding Pattern

% holding — latest first

Holder	Aug 2026	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023
Promoters	51.16	50.95	50.95	50.95	50.95	50.95	50.95	50.95	50.95	50.95	50.95	50.95
DIIs	0.11	0.11	0.11	0.11	0.11	0.11	0.11	0.11	0.11	0.11	0.11	0.11
Public	48.74	48.93	48.92	48.93	48.93	48.93	48.93	48.93	48.93	48.93	48.93	48.93
No. of Shareholders	28,384	28,384	27,173	25,649	21,441	20,337	18,231	17,844	16,321	14,989	12,974	10,963

Corporate Actions

10 records

Action	Ex Date	Record Date	Ratio	Amount (₹)	Notes
Dividend	18 Sep 2025	18 Sep 2025	—	0.01
Split	21 Mar 2025	21 Mar 2025	10:1	—
Dividend	23 Sep 2024	—	—	1.00
Bonus	19 Apr 2024	20 Apr 2024	3:1	—
Dividend	15 Sep 2023	—	—	0.50
Other	02 Feb 2023	02 Feb 2023	—	—	Right Issue of Equity Shares
Dividend	22 Sep 2022	—	—	0.50
Dividend	19 Sep 2019	—	—	0.50
Dividend	31 Aug 2018	—	—	0.50
Other	10 Mar 2014	11 Mar 2014	—	—	Reduction of Capital